BSE filing, NSE: SRAMSET. Summary written from the filing by ALFA Finder's alert engine.
Shriram Asset Management Company Ltd: key numbers
- Share price
- ₹250.80
- Market cap
- ₹424.0 Cr
- Revenue (annual)
- ₹12.14 Cr
- Net profit (annual)
- ₹-20.31 Cr
- P/E (TTM)
- -17.4×Sector 19.7×
- Promoter holding
- 70.21%-0.64% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shriram Asset Management Company Ltd
All →Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Shriram Asset Management Company Other Announcement
Shriram Asset Management Company Ltd filed its quarterly shareholding pattern disclosure for the period ended September 30, 2026, as per SEBI regulations.
Shriram Asset Management Company Other Announcement
Shriram Asset Management Company filed a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for August 2026.
Shriram Asset Management Company Employee Stock Options
Director Kartik Jain acquired 1,36,915 equity shares of Shriram Asset Management Company Ltd via ESOP, valued at Rs. 51.06 Lakh. This increases his shareholding.
- Value
- ₹0.51 Cr
Shriram Asset Management Company Employee Stock Options
Shriram Asset Management Company allotted 156,640 equity shares under its ESOP/ESPS scheme. Post-allotment, the company's paid-up share capital increased to Rs. 17.14 Crore.
Shriram Asset Management Company Other Announcement
Shriram Asset Management Company filed its Monitoring Agency Report for the quarter ended June 30, 2026. The report confirms the utilization of preferential issue proceeds aligns with objects.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.